Evidence map›Paper›PMID 20806045›Full record

ArticleMolecular vision2010

DUSP5 and DUSP6 modulate corneal epithelial cell proliferation.

Zheng Wang, Peter S Reinach, Fan Zhang, Kati-Sisko Vellonen, Arto Urtti, Helen Turner, J Mario Wolosin

Open access · greenAbstract read
In one paragraph

Article in Molecular vision, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The growth inhibitory effect of gambogic acid on pancreatic cancer cells.Naunyn-Schmiedeberg's archives of pharmacology · 2018
    Article
  8. Article
  9. Article
  10. Crosstalk between TGF-beta and MAPK signaling during corneal wound healing.Investigative ophthalmology & visual science · 2011
    Article
  11. Article
  12. Dependence of corneal epithelial cell proliferation on modulation of interactions between ERK1/2 and NKCC1.Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology · 2011
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Zheng WangDepartment of Biological Sciences, SUNY State College of Optometry, New York, NY, USA.
Peter S Reinach
Fan Zhang
Kati-Sisko Vellonen
Arto Urtti
Helen Turner
J Mario Wolosin
SUNY College of Optometry · US

Funding

OCULAR SURFACE EPITHELIAL PRECURSORSR01EY014878 · NEI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI WOLOSIN, JOSE MARIO · 2005 to 2015
$4.1M
COUPLING BETWEEN METABOLISM/IONIC TRANSPORT IN CORNEASR01EY004795 · NEI · WASHINGTON UNIVERSITY · PI REINACH, PETER S · 1985 to 2008
$2.9M
Control of Corneal Epithelial Cell ProliferationR56EY004795 · NEI · STATE COLLEGE OF OPTOMETRY · PI REINACH, PETER S · 2009 to 2009
$353k
NEI NIH HHS EY 014878NEI NIH HHS EY04795NEI NIH HHS R01 EY004795NEI NIH HHS R01 EY014878NEI NIH HHS R56 EY004795
6 · The paper itself

Abstract

purposeDual specificity phosphatases (DUSPs) modulate the duration and magnitude of phospho-activation of Erk1/2, p38 and JNK1/2, the terminal kinases (TKs) of the mitogen activated protein kinase (MAPK) cascades. Three DUSPs, DUSP1, DUSP5, and DUSP6, are overexpressed in ocular surface side population stem cells (SPSCs). Our objective was to identify the impact of these enzymes on TK phosphorylation and proliferation of corneal epithelial cells.

methodsSV40 immortalized (sv) and expanded fresh human corneal epithelial cells (efHCECs) were transduced with lentivectors to elicit expression of shRNAmir against DUSP1, DUSP5, and JNK1 to thereby create the DUSP1i, DUSP5i and JNKi cell sublines, or overexpress DUSP6 (henceforth DUSP6(+)), respectively. TK phosphorylation status and proliferation rates were determined by immunoblotting and (3)H thymidine uptake.

resultsIn both ef and svHCECs, EGF supplementation after a 24 h serum starvation caused a rapid 5-15 min spike in the phosphorylation of all three TK types. This was followed by gradual decreases to low phosphorylation levels within one h. These declines coincided with dramatic increases in DUSP1 and DUSP5 protein expression. In DUSP1i, the DUSP1 increase was abolished. All 3 TKs maintained high phosphorylation levels for at least 90 min and proliferation rates were unchanged from non-transduced cells. In DUSP5i, the DUSP5 protein increase was prevented, the post peak phosphorylation decrease occurred only on Erk1/2 and the proliferation rate increased by 50%-60%. In JNK1i, JNK1 was essentially knocked out and proliferation rates were also markedly elevated. At steady-state, DUSP1i maintained high levels of pJNK1/2 expression. In DUSP6(+) Erk1/2 phosphorylation was prevented and proliferation rates decreased to less than 50%.

conclusionsDUSP5 and DUSP6 selectively control ERK pathway activity and proliferation. The lack of an effect of DUSP1 knockdown on proliferation can be attributed to its pan-MAPK effect. The expected augmented proliferative response due to enhanced and prolonged phosphorylation of Erk1/2 following DUSP1 knockdown does not occur because a pJNK1/2 antiproliferative effect is simultaneously unleashed.

Indexed as

Cell Line, TransformedCell ProliferationDensitometryDual Specificity Phosphatase 1Dual Specificity Phosphatase 6Dual-Specificity PhosphatasesEpithelial CellsEpithelium, CornealGene Expression Regulation, EnzymologicGenetic VectorsHumansLentivirusPhosphorylationThymidineTransduction, GeneticDual Specificity Phosphatase 1Dual Specificity Phosphatase 6Dual-Specificity PhosphatasesDUSP1 protein, humanDUSP5 protein, humanDUSP6 protein, humanThymidine

Identifiers

PMID20806045
PMCPMC2927432
OpenAlexW2104235649

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.